Skip to content
Recall Observatory FDA recall evidence

Drug product

Inhub Wixela (fluticasone propionate and salmeterol inhalation powder, USP) 500/50MCG, 60 Doses of Inhalation Powder, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505. NDC: 0378-9320-32

D-0202-2024

January 26, 2022

Class II

Product summary

Firm
CARDINAL HEALTHCARE
Event
Event 89450
Status
Terminated
Classification
Class II
Quantity
1 unit
Official record key
drug-enforcement:D-0202-2024

Official wording

Reason: CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.

Code information: Batch 62002532

Distribution pattern: Nationwide USA

Derived failure modes

  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    CGMP Deviations